Pyxis Oncology
PYXS
PYXS
48 hedge funds and large institutions have $24.6M invested in Pyxis Oncology in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
2.89% less ownership
Funds ownership: 28% → 25.11% (-2.9%)
41% less capital invested
Capital invested by funds: $41.5M → $24.6M (-$16.9M)
Holders
48
Holding in Top 10
1
Calls
$81K
Puts
–
Top Buyers
| 1 | +$601K | |
| 2 | +$504K | |
| 3 | +$368K | |
| 4 |
Two Sigma Investments
New York
|
+$344K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$340K |
Top Sellers
| 1 | -$2.2M | |
| 2 | -$1.09M | |
| 3 | -$1.01M | |
| 4 |
Morgan Stanley
New York
|
-$533K |
| 5 |
Barclays
London,
United Kingdom
|
-$474K |